Unknown

Dataset Information

Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression.


ABSTRACT:

Background

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, characterized by aggressive growth and a dismal prognosis. Interleukin-33 (IL-33) and its receptor ST2 have emerged as regulators of glioma growth, but their exact function in tumorigenesis has not been deciphered. Indeed, previous studies on IL-33 in cancer have yielded somewhat opposing results as to whether it is pro- or anti-tumorigenic.

Methods

IL-33 expression was assessed in a GBM tissue microarray and public databases. As in vivo models we used orthotopic xenografts of patient-derived GBM cells, and syngenic models with grafted mouse glioma cells.

Results

We analyzed the role of IL-33 and its receptor ST2 in nonmalignant cells of the glioma microenvironment and found that

SUBMITTER: Wicher G 

PROVIDER: S-EPMC11808570 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature